AI platform aims to reduce study recruitment time


Tuesday, 11 April, 2023

AI platform aims to reduce study recruitment time

The TrialWire Patient Recruitment Platform has launched an AI-based pre-recruitment solution that aims to cut study recruitment time by 50%.

Pre-recruit’s purpose is to save time on clinical programs by having a specific number of AI-matched, screened and eligible patients ready to contact as soon as study sites are activated.

According to Trialwire, data shows Pre-recruit cuts recruitment time by more than 50%, which could save costs and reduce risk from the start. Salesforce Health Cloud securely stores patient details until study coordinators are ready to activate the site.

More than 80% of clinical trials fail to recruit patients on time, 30% of research sites are not able to meet enrolment goals and 10% of sites don’t enrol any patients, Trialwire said.

The new solution includes an SMS/Text Patient Engagement System, which aims to ensure patients are retained by managing patient expectations around contact time through the use of auto-reminders. It can support all languages and keeps a record of all conversations in the study coordinator’s dashboard.

TrialWire found that 92% of patients preferred to be contacted by SMS and up to 50% of patients could be lost since they don’t answer a call from an unknown number. In addition, it was reported that study coordinators often can't afford the time to call more than 3–4 times in the hope of connecting with the patient.

TrialWire said recruitment could start in under 24 hours because the platform doesn’t require approvals.

Image credit: iStock.com/champpixs

Related News

Telstra Health partners with Smile Digital Health for interoperability

With Australia choosing HL7 FHIR as its healthcare standard, the partnership will also support...

Virtus Health to deploy RingCentral in Australia, Europe

Virtus will roll out these solutions over the next six months at its 62 fertility clinics,...

Tool hopes to help stroke survivors facing social isolation

Researchers from The University of Queensland and Metro North Health have received funding for...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd